Everolimus Stabilizes Podocyte Microtubules via Enhancing TUBB2B and DCDC2 Expression

• Stefanie Jeruschke ,

  * E-mail: Stefanie.Jeruschke@uk-essen.de

  Affiliation Pediatric Nephrology, Pediatrics II, University Hospital Essen, Essen, Germany

  ⨯
• Kay Jeruschke,

  Affiliation Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Duesseldorf, Germany

  ⨯
• Andrew DiStasio,

  Affiliation Divisions of Human Genetics and Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America

  ⨯
• Sinem Karaterzi,

  Affiliation Pediatric Nephrology, Pediatrics II, University Hospital Essen, Essen, Germany

  ⨯
• Anja K. Büscher,

  Affiliation Pediatric Nephrology, Pediatrics II, University Hospital Essen, Essen, Germany

  ⨯
• Perihan Nalbant,

  Affiliation Center for Medical Biotechnology, Molecular Cell Biology, University of Duisburg-Essen, Essen, Germany

  ⨯
• Ludger Klein-Hitpass,

  Affiliation Institute of Cell Biology, University of Duisburg‑Essen, Essen, Germany

  ⨯
• Peter F. Hoyer,

  Affiliation Pediatric Nephrology, Pediatrics II, University Hospital Essen, Essen, Germany

  ⨯
• Jürgen Weiss,

  Affiliation Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Duesseldorf, Germany

  ⨯
• Rolf W. Stottmann,

  Affiliation Divisions of Human Genetics and Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America

  ⨯
• Stefanie Weber

  Affiliation Pediatric Nephrology, Pediatrics II, University Hospital Essen, Essen, Germany

  ⨯